You are here

  • Home
  • Archive
  • Volume 32, Issue 12
  • INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS

Article metrics

Article menu
Download PDFPDF
RCEM 2015 Abstracts
TOP SCORING NON TRAINEES
009
INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS

 

Online download statistics by month:

Online download statistics by month: November 2015 to March 2024

AbstractFullPdf
Nov 201517405
Dec 2015304013
Jan 2016155010
Feb 20169404
Mar 20168103
Apr 20167305
May 20166102
Jun 20165603
Jul 20164702
Aug 20166206
Sep 20164703
Oct 20164600
Nov 20164403
Dec 20162002
Jan 20175105
Feb 20172702
Mar 20172602
Apr 20171600
May 20172900
Jun 20171900
Jul 20173700
Aug 20171900
Sep 20173800
Oct 20173400
Nov 20173801
Dec 201711400
Jan 201812400
Feb 201810402
Mar 20189200
Apr 20186000
May 20187600
Jun 20185600
Jul 20183800
Aug 20189602
Sep 20183400
Oct 20183600
Nov 20185201
Dec 20186202
Jan 20194800
Feb 20193700
Mar 20192601
Apr 20191101
May 20191802
Jun 20191400
Jul 20191800
Aug 20192200
Sep 20191202
Oct 20192600
Nov 20191200
Dec 20191001
Jan 2020800
Feb 20201401
Mar 2020200
Apr 2020800
May 20201200
Jun 20201001
Jul 2020800
Aug 20201600
Sep 20202200
Oct 20201200
Nov 2020800
Dec 20201000
Jan 20211000
Feb 2021800
Mar 2021600
Apr 20211300
May 2021500
Sep 2021100
Oct 20211800
Nov 2021800
Dec 20211200
Jan 20221600
Feb 2022600
Mar 20222000
Apr 2022800
May 2022800
Jun 20221800
Jul 20221000
Aug 2022600
Sep 2022600
Oct 20222000
Nov 20221000
Dec 2022600
Jan 20231200
Feb 20236601
Mar 2023200
Apr 20231800
May 2023800
Jun 2023300
Jul 2023600
Aug 2023600
Sep 20231600
Oct 20232000
Nov 20234400
Dec 20233000
Jan 20241000
Feb 2024400
Mar 20243000
Total3416088